Beta-Sesquiphellandrene: A Comprehensive Reference
1. Identity and Chemical Characterization
Names and Classification
Beta-sesquiphellandrene is a sesquiterpene that is classified as a cyclohexene in which the hydrogens at position 6 are replaced by a methylidene group and in which the pro-R hydrogen at position 3 is replaced by a (2S)-6-methylhept-5-en-2-yl group. It belongs to the sesquiterpene class — a subgroup of terpenes defined by a 15-carbon skeleton. Sesquiterpenes are a diverse group of 15-carbon-long, volatile hydrocarbons assembled from three isoprenoid units, and are commonly found in plants, insects, and fungi. Despite having only 15 carbon atoms, sesquiterpenes can be found forming many different and stereochemically complex structures in nature.
The compound carries the CAS Registry Number 20307-83-9, the molecular formula C₁₅H₂₄, and a formula weight of 204.4 g/mol. Its formal IUPAC name is (6R)-3-Methylene-6-[(2S)-6-methyl-5-hepten-2-yl]cyclohexene, and it also circulates under several synonyms including (−)-β-Sesquiphellandrene, (−)-(6R,7S)-sesquiphellandrene, and Cyclohexene, 3-[(1S)-1,5-dimethyl-4-hexen-1-yl]-6-methylene-, (3R)-. The naturally occurring, biologically most-studied enantiomer is the (−) or (3R,S) form. In its isolated, neat form, beta-sesquiphellandrene is an oil.
Botanical Sources
Beta-sesquiphellandrene is a naturally occurring sesquiterpene found in various plants, notably in ginger (Zingiber officinale) and certain citrus species. It is also present in turmeric (Curcuma longa), from which it has been isolated and characterized in pharmacological studies. It has additionally been found in Tanacetum vulgare plants and in essential leaf and flower oils of Heracleum species. Among other sources documented in botanical databases, beta-sesquiphellandrene has been reported in Gundelia tournefortii, Solidago canadensis (goldenrod), and the potato (Solanum tuberosum), where it plays a role in leaf surface chemistry. Antimicrobial activity of rhizome essential oil has been extensively confirmed in vitro and attributed to its chemical components, mainly consisting of monoterpene and sesquiterpene hydrocarbons such as α-zingiberene, ar-curcumene, β-bisabolene, and β-sesquiphellandrene.
Within Zingiber officinale, beta-sesquiphellandrene is consistently identified as one of the dominant sesquiterpene hydrocarbons. Chemical analysis of ginger shows that it contains over 400 different compounds. The major constituents in ginger rhizomes are carbohydrates (50–70%), lipids (3–8%), terpenes, and phenolic compounds. Terpene components of ginger include zingiberene, β-bisabolene, α-farnesene, β-sesquiphellandrene, and α-curcumene, while phenolic compounds include gingerol, paradols, and shogaol. Its proportion varies substantially by cultivar, geographic origin, and processing conditions. Nigerian fresh ginger oil (1.02% w/v) was found to have β-sesquiphellandrene at 6.5%, while its oil from dried rhizomes (1.84% w/v) had β-sesquiphellandrene at 10.6% as a main component. In an analysis of Sub-Himalayan cultivars, α-zingiberene (32.2%) and β-sesquiphellandrene (10.9%) were the major compounds in the Gorubathane essential oil variety. In a standardized ginger simplicia analyzed by GC-MS, sesquiterpenoids were identified as the major constituents of the essential oil, including l-zingiberene (18.76%), alpha-curcumene (17.52%), sesquiphellandrene (12.92%), beta-bisabolene (7.59%), and alpha-farnesene (6.48%).
Beta-sesquiphellandrene is also a notable component in turmeric (Curcuma longa) essential oil. In a comparative analysis of four Zingiberaceae herbs, β-sesquiphellandrene (10.44%) was identified as a significant component of turmeric essential oil, following β-turmerone (25.77%) and ar-turmerone (12.28%).
Quantitative data on beta-sesquiphellandrene content in ginger essential oil varies with processing. The ratio of some essential oil components increases with storage time while beta-sesquiphellandrene may decrease with extended storage, and the viscosity of the essential oil also increases with storage time. Dried rhizomes generally yield higher sesquiterpene concentrations than fresh material. Dried ginger has a 1.0 to 3.3% essential oil content comprised mostly of sesquiterpenes supported by monoterpenes.
Common Forms and Preparations
Beta-sesquiphellandrene is encountered in commerce and research in several forms. The essential oil of ginger is typically obtained via distillation of dried ginger. The essential oil of ginger does not contain the bitter principles, however the CO₂ extract does. The CO₂ extract of ginger contains 18–23% pungent components, making the CO₂ extract more heating and diaphoretic than the essential oil. Beta-sesquiphellandrene is therefore proportionally more concentrated in the steam-distilled essential oil relative to CO₂ extracts, which also contain gingerols and shogaols. For research and pharmaceutical purposes, isolated beta-sesquiphellandrene is also available in synthetic or semi-synthetic form at high purity (>95%) as a neat oil. Ginger is recognized as safe (GRAS) as a spice, natural seasoning agent, and flavoring agent under 21 CFR 182.10. In addition, essential oils, oleoresins (solvent-free), and natural extractives (including distillates) of Zingiber officinale are considered GRAS for human consumption under 21 CFR 182.2.
2. Biosynthesis and Biochemistry
Biosynthetic Pathway
Sesquiterpenes are 15-carbon terpenes synthesized by sesquiterpene synthases using farnesyl diphosphate (FPP) as a substrate. Utilizing farnesyl diphosphate (FPP), sesquiterpene synthases generate more than 200 different sesquiterpene hydrocarbon skeletons which serve as precursors for more than 7,000 derivative molecules.
Beta-sesquiphellandrene is produced through the action of a dedicated enzyme, beta-sesquiphellandrene synthase. β-Sesquiphellandrene synthase (EC 4.2.3.123, Tps1, Os08g07100 (gene)) is an enzyme with systematic name (2E,6E)-farnesyl-diphosphate diphosphate-lyase (cyclizing, β-sesquiphellandrene-forming). Beta-sesquiphellandrene is synthesized through the action of the enzyme beta-sesquiphellandrene synthase, which catalyzes the conversion of (2E,6E)-farnesyl diphosphate into beta-sesquiphellandrene and diphosphate.
Based on previous knowledge about the reaction mechanism of other sesquiterpene synthases, the proposed reaction mechanism for the Persicaria minor beta-sesquiphellandrene synthase (PmSTS) indicates that biosynthesis begins with metal-dependent ionization of the diphosphate moiety of FPP to form a farnesyl cation and a diphosphate group. The diphosphate group will interact with and be stabilized by three Mg²⁺ ions and highly conserved positively charged residues R277, R279, and R455. The positively charged region will direct the diphosphate away from the active site. Upon ionization of substrate FPP, the farnesyl cation is required to undergo isomerization from a trans configuration to a cis configuration, for the C1–C6 cyclization to be made possible and yield a bisabolyl cation intermediate.
A sesquiterpene synthase gene encoding a 65-kDa protein responsible for producing beta-sesquiphellandrene has been isolated from the aromatic plant Persicaria minor. The recombinant P. minor sesquiterpene synthase protein (PmSTS) has been expressed, purified, and characterized. Research has also shown that a single mutation of the amino acid L454G or L454A in the active site of Persicaria minor β-sesquiphellandrene synthase leads to a more promiscuous enzyme that is capable of producing additional hydroxylated sesquiterpenes such as sesquicineole, sesquisabinene hydrate, and α-bisabolol.
Certain yeast strains, such as Saccharomyces cerevisiae, can produce beta-sesquiphellandrene through metabolic pathways involving terpenoid biosynthesis. This opens avenues for biotechnological production of the compound at scale.
3. Traditional and Historical Use
Beta-sesquiphellandrene does not have a documented history of use as an isolated compound; rather, its traditional use history is entirely embedded within the well-documented ethnomedicinal traditions surrounding its source plants — principally ginger (Zingiber officinale) and turmeric (Curcuma longa). It is one of the sesquiterpenoid constituents that modern phytochemical research has isolated and studied from plants whose therapeutic use long predates any knowledge of their individual molecular constituents.
Since thousands of years ago, ginger has been used as a food and herbal medicine in Asia and the Far East, and its medical use is well described in Chinese remedies from 400 BC. The rhizomes have been used since antiquity in the various traditional systems of medicine. The rhizomes have been used in the various traditional systems of medicine to treat cold, fever, sore throats, infectious diseases, arthritis, rheumatism, sprains, muscular aches, pains, cramps, hypertension, dementia, migraine, nervous diseases, gingivitis, toothache, asthma, stroke, and diabetes, and also used as a home remedy in treating various gastric ailments like constipation, diarrhea, dyspepsia, belching, bloating, gastritis, epigastric discomfort, gastric ulcerations, indigestion, nausea, and vomiting.
Ginger is the rhizome of Zingiber officinale, a perennial plant used alone or in compounds as a spice or remedy in ancient recipes of Iranian traditional medicine (ITM) as an effective tonic for the memory and digestive system, the opener of hepatic obstructions, aphrodisiac, for expelling compact wind from stomach and intestines, diluting, desiccating, and emollient of phlegmatic and compact humor sticking to body organs, stomach, intestine, brain, and throat. The ITM scholars believed that ginger was a vermifuge as well as a remedy for paralysis and obstructive jaundice. They also revealed that this phytomedicine cures diarrhea due to corrupted food.
Ginger originated in Southeast Asia. It has been cultivated for thousands of years as a spice as well as for medicinal purposes in countries like India, China, Nigeria, Indonesia, Bangladesh, Thailand, Philippines, and Jamaica. Ginger has traditionally been used for its antispasmodic, carminative, and diaphoretic properties. As both a herb preparation (tincture, infusion, powdered extract) and essential oil, it is used to relieve motion sickness and nausea.
Beta-sesquiphellandrene is easily available as a natural food (ginger) from ancient times, and its easy availability makes it a promising source for therapeutic exploration. Traditional therapy for controlling cough-cold problems with fast recovery includes a mixture of ginger and jaggery. Studies supported such treatment strategies or home remedies for antiviral effects; the Chinese also used similar contemporary medications such as Ge Gen Tang (consisting of ginger and sweet kudzu roots).
Isogingerol, isoshogaol, gingerdiones, 3-dihydroshogaols, dihydroparadols, acetyl gingerols, gingerdiols, mono- and di-acetyl gingerdiols, dehydrogingerdiones, diarylheptanoids, beta-sesquiphellandrene, beta-bisabolene, ar-curcumene, and diarylheptanoids have been isolated from ginger rhizomes. Its role as a significant aromatic sesquiterpenoid means that the compound has always co-occurred with the therapeutically active principles exploited by traditional healers, even if it was not specifically identified or separated until the modern era.
4. Key Constituents and Mechanisms of Action
Chemical Context Within Source Plants
Beta-sesquiphellandrene is a pure hydrocarbon sesquiterpene — it contains only carbon and hydrogen (C₁₅H₂₄) and no heteroatoms. The ginger rhizome contains two main classes of constituents: the essential oils responsible for the aroma, and the main pungent principles, gingerols and shogaols. Organic acids are also present in smaller amounts. Within the essential oil fraction, over 100 compounds have been identified in ginger extracts, most being terpenoids — mainly sesquiterpenoids (α-zingiberene, β-sesquiphellandrene, β-bisabolene, α-farnesene, ar-curcumene, zingiberol) and smaller amounts of monoterpenoids (camphene, β-phellandrene, cineole, geraniol, curcumene, citral, terpineol, borneol).
Mechanisms of Action: Antiviral Activity
The dried rhizomes of Indonesian ginger, Zingiber officinale, were investigated for antirhinoviral activity in the plaque reduction test. Fractionation by solvent extraction, solvent partition, and repeated chromatography guided by bioassay allowed the isolation of several sesquiterpenes with antirhinoviral activity. The most active of these was beta-sesquiphellandrene, with an IC₅₀ of 0.44 µM vs. rhinovirus IB in vitro. The precise molecular mechanism by which beta-sesquiphellandrene inhibits rhinovirus replication has not been fully elucidated, and the specific site of viral interaction remains under investigation.
In computational studies focused on more recently emergent viruses, researchers analyzed the interaction of beta-sesquiphellandrene with spike protein (Sp) and membrane glycoprotein polyprotein (MPp) of SARS-CoV2. The molecular docking and simulation study revealed what was described as a perfect binding pocket of Sp and MPp holding beta-sesquiphellandrene. Binding energies for MPp–bS and Sp–bS were found to be −9.5 kcal/mol and −10.3 kcal/mol respectively. ADME analysis reveals the therapeutic validations for beta-sesquiphellandrene to act as a useful pharmacoactive compound. Beta-sesquiphellandrene is proposed to provide not only an inhibitory effect on spike protein of SARS-CoV2 but also similar inhibitory effects on membrane glycoprotein polyprotein complex of SFTS virus, which could hamper the pathological initiation of the diseases caused by both viruses. These findings, however, are entirely computational (in silico) and have not been validated in cell culture or animal models.
Mechanisms of Action: Anticancer Activity
The anticancer mechanisms of beta-sesquiphellandrene have been elucidated most thoroughly in the context of turmeric-derived isolates. SQP (β-sesquiphellandrene) was found to be highly effective in suppressing cancer cell colony formation and inducing apoptosis, as shown by assays of intracellular esterase activity, plasma membrane integrity, and cell-cycle phase. SQP was found to induce cytochrome c release and activate caspases that lead to poly ADP ribose polymerase (PARP) cleavage. SQP exposure was associated with downregulation of cell survival proteins such as cFLIP, Bcl-xL, Bcl-2, c-IAP1, and survivin. These are hallmarks of mitochondria-mediated (intrinsic) apoptotic signaling. Lung cancer cells that expressed p53 were more susceptible to the cytotoxic effect of SQP than were cells that lacked p53 expression, while lack of the NF-κB-p65 protein had no effect on its activity.
Furthermore, SQP was found to be synergistic with the chemotherapeutic agents velcade, thalidomide, and capecitabine. Overall, results indicated that SQP has anticancer potential comparable to that of curcumin. All of this evidence, however, is from in vitro cell-line experiments.
Mechanisms of Action: Anti-ulcer Activity
By using the effects on HCl/ethanol-induced gastric lesions in rats, beta-sesquiphellandrene, beta-bisabolene, ar-curcumene, and 6-shogaol were isolated as anti-ulcer active principles in ginger, the dried rhizoma of Zingiber officinale Roscoe cultivated in Taiwan, together with nine known compounds and a new diarylheptanoid. The specific molecular mechanisms by which beta-sesquiphellandrene confers gastroprotection in this animal model have not been fully characterized in the primary literature; the compound was isolated through bioassay-guided fractionation rather than mechanistic dissection.
Terpene Class Context
Ginger-derived terpenes (α-zingiberene, camphene, α-curcumene, β-sesquiphellandrene, α-farnesene, β-bisabolene, α-piene) are known collectively to avoid inflammatory processes and bacterial growth, have an antioxidant effect, help to prevent high blood sugar levels, act as painkillers or protectors of gastric tissue, and exert neuroprotective and anticarcinogenic properties. Attribution of each effect specifically to beta-sesquiphellandrene alone — as opposed to the class of ginger-derived terpenes in total — requires individual constituent studies, which are limited.
5. Scientific Evidence by Area of Use
5.1 Antiviral Activity
Human/Clinical Evidence: None identified. All antiviral evidence for isolated beta-sesquiphellandrene is preclinical.
In Vitro Evidence: The pivotal study (Denyer et al., 1994) used dried rhizomes of Indonesian ginger and investigated antirhinoviral activity using the plaque reduction test. Fractionation by solvent extraction and repeated chromatography guided by bioassay allowed the isolation of several sesquiterpenes with antirhinoviral activity. The most active of these was beta-sesquiphellandrene, with an IC₅₀ of 0.44 µM vs. rhinovirus IB in vitro. This IC₅₀ value represents a very potent in vitro inhibitory concentration, placing beta-sesquiphellandrene among the most active natural sesquiterpenes identified at that time for rhinovirus inhibition.
In Silico Evidence: A molecular docking and simulation study revealed a binding pocket in both the spike protein and membrane glycoprotein polyprotein of SARS-CoV2 and SFTS viruses for beta-sesquiphellandrene. Binding energies for MPp–bS and Sp–bS were found to be −9.5 kcal/mol and −10.3 kcal/mol respectively. RMSD and RMSF values for docked complexes were found to be in the selectable range, i.e., 1 to 3 Å and 1 to 8 Å respectively.
Evidence strength: Weak to preliminary. The rhinoviral plaque reduction assay provides meaningful biological signal, but the assay is in vitro only. No animal or human studies have evaluated isolated beta-sesquiphellandrene as an antiviral agent. In silico docking results do not constitute evidence of pharmacological activity. This method of computational analysis was found to be rapid and effective and opens new doors in the domain of in silico drug discovery, but beta-sesquiphellandrene would require wet lab validations before claims of therapeutic efficacy could be made.
5.2 Anticancer / Antiproliferative Activity
Human/Clinical Evidence: None identified.
In Vitro Evidence: The most detailed study on beta-sesquiphellandrene's anticancer properties was published in Investigational New Drugs (Tyagi et al., 2015; PMID: 26521943). The researchers examined compounds other than curcumin from turmeric (Curcuma longa) that could exhibit anticancer potential. They described the isolation and characterization of β-sesquiphellandrene (SQP) as exhibiting anticancer potential comparable to that of curcumin. Among several compounds isolated from turmeric including SQP, α-curcumene, ar-turmerone, α-turmerone, β-turmerone, and γ-turmerone, only SQP was found to have antiproliferative effects comparable to those of curcumin in human leukemia, multiple myeloma, and colorectal cancer cells.
The study characterized the mechanism of action in detail: SQP was found to be highly effective in suppressing cancer cell colony formation and inducing apoptosis, as shown by assays of intracellular esterase activity, plasma membrane integrity, and cell-cycle phase. SQP was found to induce cytochrome c release and activate caspases that lead to poly ADP ribose polymerase cleavage. SQP exposure was associated with downregulation of cell survival proteins such as cFLIP, Bcl-xL, Bcl-2, c-IAP1, and survivin. Additionally, (-)-beta-sesquiphellandrene is cytotoxic to HCT116 colon cancer cells when used at a concentration of 10 µM. While lack of the NF-κB-p65 protein had no effect on the activity of SQP, lung cancer cells that expressed p53 were more susceptible to the cytotoxic effect of SQP than were cells that lacked p53 expression.
Evidence strength: Preliminary. All evidence derives from in vitro cell-line experiments. Current research primarily relies on in vitro (laboratory) experiments. Further in vivo and clinical trials are necessary to assess the safety and efficacy of beta-sesquiphellandrene in humans. The demonstration of synergy with approved chemotherapeutics (velcade, thalidomide, capecitabine) in cell lines is mechanistically interesting but requires in vivo validation.
5.3 Gastroprotective / Anti-ulcer Activity
Human/Clinical Evidence: No human clinical trials have studied isolated beta-sesquiphellandrene for gastrointestinal outcomes. Clinical trials on ginger as a whole have been conducted for nausea and dyspepsia, but these cannot be attributed to any single constituent.
Animal Evidence: Research revealed (−)-β-sesquiphellandrene, β-bisabolene, ar-curcumene, and 6-shogaol as anti-ulcer active principles in ginger via experiments using HCl/ethanol-induced gastric lesions. This bioassay-guided isolation experiment used a rat model of chemically induced gastric damage, establishing a dose-response signal for the isolated compounds; however, specific dose and efficacy data for beta-sesquiphellandrene alone compared to positive controls were not detailed in the available public literature.
Evidence strength: Preliminary — animal/preclinical only. The gastric lesion assay provides a credible mechanistic starting point, but it is a single animal experiment with no human translation data.
5.4 Anti-inflammatory and Antioxidant Activity
Human/Clinical Evidence: None specifically attributable to isolated beta-sesquiphellandrene.
Preclinical/In Vitro Evidence: Ginger-derived terpenes including β-sesquiphellandrene are collectively described as known to avoid inflammatory processes and bacterial growth, have an antioxidant effect, help to prevent high blood sugar levels, act as painkillers or protectors of gastric tissue, and exert neuroprotective and anticarcinogenic properties. However, most evidence in this area has been generated for the essential oil fraction as a whole or for other individual ginger constituents (e.g., 6-gingerol, 6-shogaol) rather than for beta-sesquiphellandrene in isolation.
Evidence strength: Indirect. Beta-sesquiphellandrene is consistently listed among the terpene constituents of ginger essential oil, which shows antioxidant and anti-inflammatory activity in laboratory models, but constituent-specific mechanistic data for this compound alone are sparse. Anti-inflammatory, antioxidant, antitumor, and antiulcer effects of ginger have been proven in many scientific studies, and some of the ancient applications of ginger as a home remedy have been confirmed in humans, but the attribution of these effects to individual sesquiterpenes requires compound-specific studies not yet widely published.
5.5 Ginger Essential Oil in Gastrointestinal Disorders (Contextual Clinical Evidence)
While not attributable to beta-sesquiphellandrene in isolation, the systematic review context for ginger is relevant because beta-sesquiphellandrene is one of the main volatile constituents of the preparations tested clinically. Data from a systematic review of clinical trials indicates that divided lower daily dosage of 1500 mg ginger is beneficial for nausea relief. Because of the limited number of studies on some other gastrointestinal disorders, the results may not be as well-powered as to find significant results. Therefore, more extensive and well-controlled human studies of ginger or its standard extracts are required to demonstrate its full efficacy as a gastroprotective agent.
6. Body Systems and Health Areas of Association
- Gastrointestinal system: Beta-sesquiphellandrene has been identified as an anti-ulcer active principle in bioassay-guided animal studies and is one of the aromatic terpenes of ginger essential oil long used for digestive complaints.
- Immune system / antiviral defense: Beta-sesquiphellandrene has been found in Z. officinale and has demonstrated antiviral and anticancer activities in preclinical models. Its sub-micromolar IC₅₀ against rhinovirus IB makes it the most potent antirhinoviral sesquiterpene isolated from ginger.
- Oncology (experimental): In vitro evidence associates beta-sesquiphellandrene with antiproliferative effects in human leukemia, multiple myeloma, colorectal cancer, and lung cancer cell lines, operating through mitochondria-mediated apoptosis and caspase activation.
- Antimicrobial: As a component of ginger essential oil, beta-sesquiphellandrene contributes to the overall antimicrobial activity of that oil, which has been extensively confirmed in vitro and attributed to sesquiterpene hydrocarbons such as α-zingiberene, ar-curcumene, β-bisabolene, and β-sesquiphellandrene.
- Metabolic / glycemic: Both curcuminoids and sesquiterpenoids in turmeric exhibit hypoglycemic effects via peroxisome proliferator-activated receptor-γ (PPAR-γ) activation and suppress an increase in blood glucose levels in type 2 diabetic KK-Ay mice. The effect was synergistic when both curcuminoids and sesquiterpenoids in turmeric were applied together. Beta-sesquiphellandrene is among the turmeric sesquiterpenoids studied in this context, but specific dose-response data for the isolated compound are lacking.
7. Dosage Forms and Reported Dosages
No standardized therapeutic dosage for isolated beta-sesquiphellandrene has been established in clinical practice, as no human clinical trials have been completed using the purified compound. The following dosages and concentrations reflect those reported in preclinical and in vitro research.
- Antiviral (in vitro): The most active antirhinoviral concentration was an IC₅₀ of 0.44 µM vs. rhinovirus IB in vitro.
- Anticancer (in vitro): Beta-sesquiphellandrene is cytotoxic to HCT116 colon cancer cells when used at a concentration of 10 µM.
- Ginger extract (clinical — for context only): Divided lower daily dosage of 1500 mg ginger is beneficial for nausea relief in the clinical context of whole-ginger preparations. Beta-sesquiphellandrene content in such preparations is not standardized and is not stated as a dose in these trials.
- Essential oil in GC-MS studies: In one ginger essential oil analysis, β-sesquiphellandrene constituted 9.92% of the total oil composition. The clinical relevance of this concentration for any health outcome has not been established.
In research-grade supply, beta-sesquiphellandrene is available as a synthetic neat oil at >95% purity for laboratory use. No validated human dosing protocol, extract standardization specifying beta-sesquiphellandrene content, or pharmacokinetic data in humans are currently available in the peer-reviewed literature.
8. Safety Considerations and Interactions
Regulatory Status and General Safety of Source Plants
Ginger is classified as 'Generally Recognised as Safe' (GRAS) by the United States Food and Drug Administration (FDA); however, few specific studies have been carried out to evaluate the safety of ginger use during pregnancy and lactation. Ginger is included in the official pharmacopoeias of several western countries. This GRAS status applies to ginger as a food ingredient and to extracts for human consumption, not to isolated beta-sesquiphellandrene.
Isolated Compound Toxicology
Data on specific human toxicity of isolated beta-sesquiphellandrene is limited. The toxicity from single components may not predict the potential toxicity of botanical ingredients as complex substances. No dedicated toxicological studies (e.g., LD₅₀ determination, repeat-dose toxicity, genotoxicity) for isolated beta-sesquiphellandrene have been identified in the peer-reviewed literature available to this review.
Drug Interactions (via Ginger)
Induction or inhibition of CYP enzymes is a major determinant of the occurrence of drug-drug interactions. Ginger constituents have been studied for CYP enzyme modulation, but whether beta-sesquiphellandrene specifically contributes to such interactions is not established in the available literature. This consideration is relevant given that beta-sesquiphellandrene is one of the primary volatile sesquiterpenoids in ginger essential oil.
Use During Pregnancy
Ginger is classified as 'Generally Recognised as Safe' (GRAS) by the FDA; however, few specific studies have been carried out to evaluate the safety of ginger use during pregnancy and lactation. In 2008, the Danish company Ferrosan A/S withdrew their product GraviFrisk — a product containing 6 g of dried ground ginger — from the market due to concerns surrounding the lack of safety data with respect to the use of supplements containing highly concentrated ginger extracts by pregnant women. No separate safety evaluation for isolated beta-sesquiphellandrene during pregnancy exists.
Storage Stability
Analytical data indicate that the concentration of (−)-β-sesquiphellandrene in ginger essential oil decreases with storage time, while other components such as (+)-ar-curcumene and (−)-α-zingiberene increase, and the viscosity of the essential oil increases with storage time. This instability has implications for quality control of ginger essential oils and preparations claimed to deliver consistent levels of beta-sesquiphellandrene.
Evidence Gap Summary
While initial research suggests potential applications of beta-sesquiphellandrene in antiviral and anticancer therapy, further investigation is crucial. More extensive studies are required to confirm the observed biological activities and elucidate the underlying mechanisms of action. Current research primarily relies on in vitro experiments. Further in vivo and clinical trials are necessary to assess the safety and efficacy of beta-sesquiphellandrene in humans. No human pharmacokinetic studies, bioavailability data, toxicology reports, or randomized controlled trials have been published for the isolated compound as of the time this article was compiled.
References
Go back